Related references
Note: Only part of the references are listed.Molecular Imaging for Cancer Immunotherapy: Seeing Is Believing
Madiha Saeed et al.
BIOCONJUGATE CHEMISTRY (2020)
Development and Evaluation of Interleukin-2-Derived Radiotracers for PET Imaging of T Cells in Mice
Elly L. van der Veen et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Immunotherapy by Immune Checkpoint Inhibitors and Nuclear Medicine Imaging: Current and Future Applications
Pierre Decazes et al.
CANCERS (2020)
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano-Goroff et al.
CELL RESEARCH (2020)
Novel Nuclear Medicine Imaging Applications in Immuno-Oncology
Stefano Frega et al.
CANCERS (2020)
Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions
Massimo Ralli et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls
Steve Y. Cho et al.
SEMINARS IN NUCLEAR MEDICINE (2020)
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
Wolfgang M. Brueckl et al.
BMC CANCER (2020)
Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy
Hannan Gao et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates
Manpreet Sambi et al.
JOURNAL OF ONCOLOGY (2019)
Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics
Romain-David Seban et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature
Nicolas Aide et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Noninvasive imaging in cancer immunotherapy: The way to precision medicine
Yang Du et al.
CANCER LETTERS (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Cold Tumors: A Therapeutic Challenge for Immunotherapy
Paola Bonaventura et al.
FRONTIERS IN IMMUNOLOGY (2019)
Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments
Jong W. Yu et al.
PLOS ONE (2018)
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
Suzanne I. S. Mosely et al.
CANCER IMMUNOLOGY RESEARCH (2017)
18F-FLT and 18F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results
Shi Qi et al.
SCIENTIFIC REPORTS (2017)
Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response
Benjamin M. Larimer et al.
CANCER RESEARCH (2017)
Molecular Imaging of Immunotherapy Targets in Cancer
Emily B. Ehlerding et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Toxicities of Immunotherapy for the Practitioner
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Noninvasive imaging of immune responses
Mohammad Rashidian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Immunogenicity of Murine Solid Tumor Models as a Defining Feature of In Vivo Behavior and Response to Immunotherapy
Melissa G. Lechner et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
[18F]FLT-PET in oncology:: current status and opportunities
LB Been et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Share Paper
